HIV Viral Load Rebound / Increase

After 4 Years of Viral Suppression with HAART, HIV Rebound Rates in Patients with Multiple Prior Treatment Failures Resemble Those in Individuals with No Prior Failure    - 7/07/07

Treatment Interruption Linked to Increased Risk of HIV Rebound   12/01/06

Certain Antiretroviral Drugs Have Higher HIV Rebound Rates Than Others in Patients with HIV Viral Loads <50 copies/mL - 9/19/05

Certain Antiretroviral Drugs Have Higher HIV Rebound Rates Than Others in Patients with HIV Viral Loads <50 Copies/mL - 9/19/05

HAART Produces Significant Immune Reconstitution Even in Children Who Do Not Reach Undetectable Viral Loads or Who Have Viral Load Rebound - 6/20/05

Viral Rebound in Patients on First-line, PI-containing HAART Suggests a Lack of Adherence Rather Than the Selection of Resistant Variants - 4/04/05

Treatment Interruption Fails to Yield a Clinically Significant Benefit - 1/19/05

Treatment Interruptions in Chronic HIV Infection - 1/19/05

Can Therapeutic Immunization with DermaVir Control HIV Rebound? - 1/10/05

Poor HAART Adherence Among Women Fuels Gender Differences in HIV Rebound - 1/07/05

Patterns of Drug Resistance Emerging from Patients Undergoing Intensification Therapy with Tenofovir  - 10/20/04

Use of Prednisolone in HIV-associated Tuberculous Pleurisy Is Not Recommended  - 08/16/04

Patients Who Use Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Before HAART Experience an Increased Rate of Virus Rebound  - 08/16/04